Author(s): Gaur, S., et al. “Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: A case report.” Cancer Biol Med. 9.1
Malignancy is a gathering of maladies including irregular cell development with the possibility to attack or spread to different pieces of the body These diverge from kind tumors, which don't spread. Possible signs and side effects incorporate a bump, unusual dying, delayed hack, unexplained weight reduction, and an adjustment in entrail movements. While these manifestations may demonstrate disease, they can likewise have other causes. Over 100 sorts of diseases influence people.
Numerous malignant growths can be forestalled by not smoking, keeping up a sound weight, not drinking an excess of liquor, eating a lot of vegetables, products of the soil grains, inoculation against certain irresistible maladies, not eating an excess of prepared and red meat and maintaining a strategic distance from an excess of daylight exposure. Early location through screening is helpful for cervical and colorectal cancer. The advantages of screening in bosom disease are disputable. Disease is regularly rewarded with a blend of radiation treatment, medical procedure, chemotherapy and focused on therapy. Pain and indication the executives are a significant piece of care. Palliative consideration is especially significant in individuals with cutting edge disease.The possibility of endurance relies upon the sort of malignancy and degree of illness toward the beginning of treatment. In youngsters under 15 at finding, the five-year endurance rate in the created world is on normal 80%. For malignant growth in the United States, the normal five-year endurance rate is 66%
Referred From: https://www.iomcworld.org/medical-journals/cancer-50248.html
Author(s): Liu, Y.I., et al. “Hepatic epithelioid hemangioendothelioma.” Dig Dis Sci. 56.2
Author(s): Kim, S.G., et al. “A case of primary hepatic epithelioid hemangioendothelioma mimicking metastatic carcinoma.” Korean J Gastroenterol. 50.1
Author(s): Mertens, F
Author(s): Mukherjee, S., et al. “Hemangioendothelioma of soft tissue: Cytological dilemma in two unusual sites.” J Cytol. 29
Author(s): Radzikowska, E., et al. “Pulmonary epithelioid hemangioendothelioma - interferon 2-alpha treatment- Case Report.” Pneumol Allergol Pol. 76.4
Author(s): Gordillo, G.M., et al. “A key angiogenic role of monocyte chemoattractant protein-1 in hemangioendothelioma proliferation.” Am J Physiol Cell Physiol. 4.C
Author(s): Budousquie, A.C., et al. “Complex translocation (7;22) identified in an epithelioid hemangioendothelioma.” Cancer Genet Cytogenet. 92
Author(s): Antonescu, C.R., et al. “ Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.” Genes Chromosomes Cancer. 52.8
Author(s): Mascarelli, P.E., et al. “Bartonella species bacteremia in two patients with epithelioid hemangioendothelioma.” J Clin Microbiol. 49
Author(s): Lau, K., et al. “Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement.” Chest. 140
Author(s): Gomez-Arellano, L.I., et al. “Multicentric epithelioid hemangioendothelioma of bone. Report of a case with radiologic-pathologic correlation.”Annals Diagn Pathol. 16
Author(s): Pommaret, E., et al. Colonic metastases of an epithelioid hemangioendothelioma: an unusual cause of periumbilical pain and wheight loss.” Dig Liver Dis. 43.5
Author(s): Bagan, P., et al. “Prognostic factors and surgical indications of pulmonary epithelioid hemangioendothelioma: A review of the literature.” Ann Thorac Surg. 82.6
Author(s): Kim, S.J., & Kim, Y.C. “Unusual extrahepatic metastasis to the soft tissue of the left cervical neck area from hepatic epithelioid hemangioendothelioma.” Hepatology. 54.4
Author(s): Gherman,C.D., & Fodor, D. “Epithelioid hemangioendothelioma of the forearm with radius involvement: Case report.” Diagn Pathol. 6
Author(s): Larochelle, O., et al. “Best Cases from the AFIP- Epithelioid hemangioendothelioma of bone.” Radio Graphics. 26.1
Author(s): Rest, C.C., et al. “FDG PET in epithelioid hemangioendothelioma.” Clin Nucl Med. 29.12
Author(s): Murali, R., et al. Cytologic features of epithelioid hemangioendothelioma.”Am J Clin Pathol. 136.5
Author(s): Teo, S.K., et al. “Intravascular bronchioloalveolar tumor: a 20 year survival.” Med J Aust. 142
Author(s): Christopher, D
Author(s): Van, K.M.E.E., et al. “Epithelioid hemangioendothelioma of the lung: clinical and pathological pitfalls.” Eur Respir J. 8
Author(s): Pinet, C., et al. “Aggressive form of pleural epithelioid hemangioendothelioma: complete response after chemotherapy.” Eur Respir J. 14.1
Author(s): Drazin, D., et al. “Epithelioid hemangioendothelioma of the mastoid: resection for recurrence and adjuvant radiation with 8-year follow up.” Case Rep Surg.2013